Radiotherapy with Cyclin-Dependent Kinase 4/6 Inhibitors: A Multi-institutional Safety and Toxicity Study
This journal activity provides practitioners with the knowledge in understanding whether radiotherapy when given with Cyclin-Dependent Kinase (CDK) 4/6 inhibitors is associated with a different toxicity profile than radiotherapy alone.
Category
  • Breast Cancer
Format
  • Journal SA-CME
Credits
  • 1.00 Certificate of Attendance
  • 1.00 SA-CME